Unlisted
| Company Name | (주)바이오인프라생명과학 |
| English Name | BioInfra Life Science Inc. |
| Business Reg. No. | 1218142247 |
| CEO | 이덕윤 |
| Address | 서울특별시 금천구 가산로9길 66 제1동 712호(가산동, 더리즌밸리지식산업센터) |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Established | 20010130 |
| Phone | 02-6271-0102 |
| Website | bioinfra.co.kr |
| Regular Employees | 4persons |
| Corp. Reg. No. | 1246110241808 |
Venture Certified
| 신기술기업(고도기술수반산업) | 2003-06-18 ~ 2005-06-17 | 031135032200842 | 2003-06-18 |
| 신기술기업(고도기술수반산업) | 2006-05-15 ~ 2008-05-14 | 61122032300712 | 2003-06-18 |
| 기술평가보증기업(기금) | 2008-05-15 ~ 2009-05-14 | 20080104169 | 2003-06-18 |
| 기술평가보증기업(기금) | 2009-07-13 ~ 2011-07-12 | 20090106685 | 2003-06-18 |
| 기술평가보증기업(기금) | 2011-07-13 ~ 2013-07-12 | 20110104380 | 2003-06-18 |
| 기술평가보증기업(기금) | 2013-07-13 ~ 2015-07-12 | 20130107014 | 2003-06-18 |
| 연구개발유형 | 2015-10-20 ~ 2017-10-19 | 20150111010 | 2003-06-18 |
| 연구개발유형 | 2017-10-20 ~ 2019-10-19 | 20170113491 | 2003-06-18 |
| 연구개발유형 | 2019-10-20 ~ 2021-10-19 | 20190114745 | 2003-06-18 |
| 연구개발유형 | 2021-10-20 ~ 2024-10-19 | 20211013020016 | 2003-06-18 |
| 벤처투자유형 | 2024-10-20 ~ 2027-10-19 | 20241105010003 | 2003-06-18 |
Revenue CAGR -12.8%
| Item | 2023 | 2022 |
|---|---|---|
| Revenue | 13B | 15B |
| Operating Profit | -22B | -20B |
| Net Profit | -25B | -15B |
| Total Assets | 26B | 49B |
| Total Liabilities | 39B | 38B |
| Total Equity | -13B | 11B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -22B
2 Consecutive Years of Net Loss
▼ 12.8%
▼ 8.6%
▼ 24.5%
▼ 186.2%
▲ 241.2%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 이덕윤 | 사내이사 | 경영총괄 | - |
| 안 욱 | 사외이사 | 이사회 위원 | - |
| 황만순 | 기타비상무이사 | 이사회 위원 | - |
| 김태겸 | 감사 | 감사 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 3persons |
| CEO | 이덕윤 |
| Est. Avg. Annual Salary | 6,12510K (51010K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | 0persons |
| NPS Join Date | 2001-02-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "서울 금천구",
"ceo_name": "이덕윤",
"certificate": [
{
"cert_number": "031135032200842",
"changes": "",
"disclosure_date": "2003-06-18",
"first_cert_date": "2003-06-18",
"no": "1",
"type": "신기술기업(고도기술수반산업)",
"valid_period": "2003-06-18 ~ 2005-06-17"
},
{
"cert_number": "61122032300712",
"changes": "",
"disclosure_date": "2006-05-15",
"first_cert_date": "2003-06-18",
"no": "2",
"type": "신기술기업(고도기술수반산업)",
"valid_period": "2006-05-15 ~ 2008-05-14"
},
{
"cert_number": "20080104169",
"changes": "",
"disclosure_date": "2008-06-18",
"first_cert_date": "2003-06-18",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2008-05-15 ~ 2009-05-14"
},
{
"cert_number": "20090106685",
"changes": "",
"disclosure_date": "2009-07-13",
"first_cert_date": "2003-06-18",
"no": "4",
"type": "기술평가보증기업(기금)",
"valid_period": "2009-07-13 ~ 2011-07-12"
},
{
"cert_number": "20110104380",
"changes": "",
"disclosure_date": "2011-07-11",
"first_cert_date": "2003-06-18",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2011-07-13 ~ 2013-07-12"
},
{
"cert_number": "20130107014",
"changes": "",
"disclosure_date": "2013-07-10",
"first_cert_date": "2003-06-18",
"no": "6",
"type": "기술평가보증기업(기금)",
"valid_period": "2013-07-13 ~ 2015-07-12"
},
{
"cert_number": "20150111010",
"changes": "",
"disclosure_date": "2015-10-20",
"first_cert_date": "2003-06-18",
"no": "7",
"type": "연구개발유형",
"valid_period": "2015-10-20 ~ 2017-10-19"
},
{
"cert_number": "20170113491",
"changes": "",
"disclosure_date": "2017-11-20",
"first_cert_date": "2003-06-18",
"no": "8",
"type": "연구개발유형",
"valid_period": "2017-10-20 ~ 2019-10-19"
},
{
"cert_number": "20190114745",
"changes": "",
"disclosure_date": "2019-12-13",
"first_cert_date": "2003-06-18",
"no": "9",
"type": "연구개발유형",
"valid_period": "2019-10-20 ~ 2021-10-19"
},
{
"cert_number": "20211013020016",
"changes": "",
"disclosure_date": "2021-10-13",
"first_cert_date": "2003-06-18",
"no": "10",
"type": "연구개발유형",
"valid_period": "2021-10-20 ~ 2024-10-19"
},
{
"cert_number": "20241105010003",
"changes": "",
"disclosure_date": "2024-11-05",
"first_cert_date": "2003-06-18",
"no": "11",
"type": "벤처투자유형",
"valid_period": "2024-10-20 ~ 2027-10-19"
}
],
"company_name": "(주)바이오인프라생명과학",
"financials": {
"2022": {
"capital_stock": 7644331000,
"cost_of_sales": 433107000,
"current_assets": 3364332000,
"current_liabilities": 2536859000,
"gross_profit": 1059032000,
"net_income": -1455362000,
"net_income_bs": -1455362000,
"non_current_assets": 1548446000,
"non_current_liabilities": 1273080000,
"non_operating_expenses": 818444000,
"non_operating_income": 1359655000,
"operating_profit": -1996573000,
"revenue": 1492138000,
"sga_expenses": 3055605000,
"total_assets": 4912778000,
"total_equity": 1102839000,
"total_liabilities": 3809939000
},
"2023": {
"capital_stock": 7644331000,
"cost_of_sales": 355383000,
"current_assets": 1371959000,
"current_liabilities": 2686739000,
"gross_profit": 946168000,
"net_income": -2453099000,
"net_income_bs": -2453099000,
"non_current_assets": 1230495000,
"non_current_liabilities": 1232089000,
"non_operating_expenses": 450841000,
"non_operating_income": 166010000,
"operating_profit": -2168268000,
"revenue": 1301551000,
"sga_expenses": 3114436000,
"total_assets": 2602454000,
"total_equity": -1316374000,
"total_liabilities": 3918829000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "999,999,000",
"changes": "999,999,000",
"date": "2021-06-16"
}
],
"phone": "02-6271-****",
"source": "pg_migration"
}{
"address": "서울특별시 금천구 가산로9길",
"brno": "121814****",
"cappedWarning": false,
"companyName": "(주)바이오인프라생명과학",
"estimatedAvgAnnualSalary": 61247160,
"estimatedAvgMonthlySalary": 5103930,
"fetchedAt": "2026-03-05T13:41:42.160Z",
"industryCode": "730000",
"industryName": "기타 인문 및 사회과학 연구개발업",
"joinDate": "20010201",
"last12MonthsHired": 0,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 0,
"leaveDate": null,
"monthlyPensionAmount": 1454620,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6383587",
"status": "1",
"styleCode": "1",
"subscriberCount": 3,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |